KR20020092021A - Opuntia ficus-indica fruit extract and immuno-activating agent comprising it as an effective component - Google Patents

Opuntia ficus-indica fruit extract and immuno-activating agent comprising it as an effective component Download PDF

Info

Publication number
KR20020092021A
KR20020092021A KR1020010030869A KR20010030869A KR20020092021A KR 20020092021 A KR20020092021 A KR 20020092021A KR 1020010030869 A KR1020010030869 A KR 1020010030869A KR 20010030869 A KR20010030869 A KR 20010030869A KR 20020092021 A KR20020092021 A KR 20020092021A
Authority
KR
South Korea
Prior art keywords
extract
fruit extract
flavor
present
opuntia ficus
Prior art date
Application number
KR1020010030869A
Other languages
Korean (ko)
Inventor
김경임
오상훈
Original Assignee
김경임
오상훈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김경임, 오상훈 filed Critical 김경임
Priority to KR1020010030869A priority Critical patent/KR20020092021A/en
Publication of KR20020092021A publication Critical patent/KR20020092021A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/33Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: An immunoactive agent containing a fruit extract of Opuntia ficus-indica var. Saboten Makino showing immunoactive activity against macrophages and complement systems is provided which is used for the prevention and treatment of various disorders. CONSTITUTION: Opuntia ficus-indica is extracted with cold water at 20 to 30deg.C, hot water at 70 to 100deg.C or an organic solvent such as methanol or ethanol. To overcome discoloration problems caused by degradation of pigment stability in accordance with the progression of a manufacturing process of an immunoactive agent, pigment stability according to a pH of the extract is assayed, and a functional test in accordance with kinds of flavor, sugar and acid added to improve the flavor peculiar to the Opuntia ficus-indica is performed and then a physiological effect on the Opuntia ficus-indica is examined.

Description

손바닥 선인장 열매 추출물 및 이를 유효성분으로 함유하는 면역활성강화제 {OPUNTIA FICUS-INDICA FRUIT EXTRACT AND IMMUNO-ACTIVATING AGENT COMPRISING IT AS AN EFFECTIVE COMPONENT}Palm Cactus Fruit Extract and Immunostimulating Agent Containing It as an Active Ingredient

본 발명은 손바닥 선인장 열매 추출물 및 이를 유효성분으로 함유하는 면역활성강화제에 관한 것으로서, 더욱 상세하게는 물 또는 유기 용매, 바람직하게 20∼30℃의 냉수 또는 에탄올을 사용하여 손바닥 선인장 열매로부터 추출한 선인장 추출물과, 이를 유효성분으로 함유하는 대식세포계 및 보체계 면역활성강화용 천연 면역활성강화제에 관한 것이다.The present invention relates to a palm cactus fruit extract and an immunoactive enhancer containing the same as an active ingredient. More specifically, cactus extract extracted from palm cactus fruit using water or an organic solvent, preferably cold water or ethanol at 20 to 30 ° C. And it relates to a natural immune activity enhancing agent for enhancing the immune activity of macrophages and complement system containing it as an active ingredient.

제주도에서 자생 또는 재배되고 있는 손바닥 선인장(Opuntia ficus-indica)은 열대지역 유래의 다년초로서 열매를 먹을 수 있으며, 식이섬유와 비타민 C를 다량 함유할 뿐만 아니라, 페놀성 물질 및 칼슘 성분에 의한 항암·항돌연변이 효과, 노화 방지, 변비 및 성인병 치료에 탁월한 효과가 있는 것으로 알려져 있다[中葯大辭典, 上海科學技術出版社 小學官 ; 東京, p2731 (1985)]. 한방에서는 신경성 통증을 치료하거나, 건위, 자양강장제, 소염 해독, 해열진정제, 이질 등의 질병을 치료하는데 이용하여 왔으며, 또한 하혈을 다스리는 목적으로도 사용가능한 것으로 알려져 있다[中藥大事典, 新文豊 出版社, 上卷, p483-489 (1981)]. 위궤양에 걸린 실험용 흰쥐를 대상으로 실험한 손바닥 선인장의 항궤양 효과에 관한 연구 결과를보면 선인장을 섭취한 쥐에 비하여 섭취하지 않은 쥐가 궤양 발병률이 매우 높고, 종합적인 조직병리학적 소견 결과 선인장은 항궤양 효과가 있는 것으로 보고되어 있다[이후장 : 랫드의 스트레스성 위궤양에 대한 선인장의 항궤양작용에 관한 연구. 서울대학교 보건대학원 석사학위논문(1997)]. Opuntia ficus-indica , native or cultivated on Jeju Island, is a perennial herb derived from the tropics and can be eaten as a fruit. It contains high amounts of dietary fiber and vitamin C, as well as anticancer and phenolic substances. It is known to have an excellent antimutagenic effect, anti-aging, constipation, and treatment of adult diseases [中葯 大 辭典, 上海 科學 技術 出版社 小學 官; Tokyo, p2731 (1985). In oriental medicine, it has been used to treat neurological pain or to treat diseases such as health, nourishment tonic, anti-inflammatory detoxification, antipyretics, and dysentery, and it is also known to be used for the purpose of controlling bleeding [中藥 大事 典, 新 文 豊].出版社, 上 卷, p483-489 (1981). Studies on the anti-ulcer effect of palm cactus in experimental rats with gastric ulcer showed that the incidence of ulcer was higher in rats that did not consume cactus compared with rats that consumed cactus. It has been reported to have an ulcer effect. [Chapter: A study on the anti-ulcer activity of cactus against stressful gastric ulcer in rats. Seoul National University Master's Thesis (1997).

선인장 열매의 붉은색은 베타라인(betalain)류 색소에 기인하는 것으로 베타라인은 적색의 베타시아닌(betacyanin)류와 황색의 베타크산틴 (betaxanthin)류로 분류되며, 흔한 적색색소로 알려진 안토시아닌(anthocyanin)류 색소의 적색과는 구별되는 것으로 알려져 있다. 특히, 베타시아닌류 색소는 가장 많은 부분을 차지하는 베타닌(betanin)과 그 이성질체인 이소베타닌(isobetanin), 필로칵틴 (phyllocactin) 및 이소필로칵틴(isophyllocactin)으로 구성되며, 이들 색소의 최대흡수파장은 537∼538nm이다[Piattelli, M. 등, Betacyanins of the family cactaceae.Phytochemistry,8, 1503 (1969)].The red color of cactus fruits is due to betaline pigments, which are classified into red betacyanins and yellow betaxanthins, and anthocyanins, commonly known as red pigments. It is known that it is distinguished from the red of the) dye. In particular, the beta cyanine pigments are composed of betanin and its isomers isobetanin, phyllocactin and isophyllocactin, which occupy the largest portion, and the maximum absorption of these pigments. The wavelength is 537-538 nm [Piattelli, M. et al., Betacyanins of the family cactaceae. Phytochemistry , 8 , 1503 (1969).

한편, 대식세포는 체내 면역 기전인 선천적 면역과 후천적 면역에 모두 관여하는 세포로 이물질 또는 염증유발 물질에 노출되었을 경우에 탐식작용 (phagocytosis), 집적작용(adherence capacity), 프로스타글란딘 분비작용 (prostaglandin secretion) 등을 증가시키고, 여러 가지 단백질류 가령 효소의 합성을 증가시키는 등의 기능적 변화를 유도한다. 인터페론(Interferon, IFN), 리포폴리사카라이드 (lipopolysaccharide, LPS) 등의 면역 조절물질에 의해 대식세포에서 분비된 사이토카인(TNF-α, IL-1, IL-8, IL-6, IL-12), 과산화수소(H2O2), 일산화질소(NO), 세포융해 프로테아제(cytolytic protease) 등이 암세포에 대한 세포독성을 나타내는 물질로 알려져 있다. 또한, 활성화된 대식세포는 항미생물 작용 및 항암작용이 있다고 알려져 있다.Macrophages, on the other hand, are involved in both the innate and acquired immunity of the body and are known to have phagocytosis, adheence capacity, and prostaglandin secretion when exposed to foreign or inflammatory agents. Increase the back, and induces functional changes such as increasing the synthesis of various proteins such as enzymes. Cytokines (TNF-α, IL-1, IL-8, IL-6, IL-12 secreted from macrophages by immune modulators such as Interferon (IFN) and lipopolysaccharide (LPS)) ), Hydrogen peroxide (H 2 O 2 ), nitrogen monoxide (NO), cytolytic protease (cytolytic protease) and the like are known to be cytotoxic to cancer cells. Activated macrophages are also known to have antimicrobial and anticancer effects.

대식세포와 더불어 보체계(complement system)는 체액성 면역 및 세포성 면역에 모두 관여하는 면역계의 주요 인자로 대식세포 등의 탐식세포(phagocytic cell)에는 보체계 활성화 과정에서 생긴 분해산물의 수용체들이 존재하는데 이는 보체계가 대식세포와 같은 주요 면역계 세포들의 면역 반응에 직접적으로 관여하고 있음을 의미한다. 보체계의 주요 역할은 병원체의 옵소닌작용(opsonization), 염증세포(inflammatory cell)의 염증부위로의 집적작용(adherence capacity), 병원체의 직접적인 용혈작용 세가지를 들 수 있다. 이중에서 병원체의 옵소닌작용과 염증세포의 염증부위로의 집적작용은 보체와 대식세포가 함께 관여하는 면역작용이라 알려져 있다.In addition to macrophages, the complement system is a major factor in the immune system that is involved in both humoral and cellular immunity. In phagocytic cells, such as macrophages, there are receptors of degradation products from the activation of the complement system. This means that the complement system is directly involved in the immune response of major immune system cells, such as macrophages. The main roles of the complement system are three: opsonization of pathogens, adherence capacity of inflammatory cells into inflammatory sites, and direct hemolytic action of pathogens. Of these, opsonization of pathogens and accumulation of inflammatory cells into inflammatory sites are known as immune responses involving complement and macrophages.

탁월한 생리 활성 효과에도 불구하고, 국내에서는 체계적이고 심도있는 선인장에 대한 학술적 연구가 미비할 뿐만 아니라 현재는 생산량에 비해 소비량이 한계에 다다르고 있어 국내 선인장 재배농가의 부담이 가중되고 있는 실정이다. 이에 비해 일본의 후꾸오까 미야자끼현이나 남아메리카 지역의 선인장 농원에서는 가공식품 형태로 선인장을 고유의 특산품으로 자리매김하고 있는 실정이다[Lopez, P. O. and Burgos, R. R. : Canned prickly pear juice.Technologia De Alimentos,8, 237 (1973)].Despite the excellent physiological activity, systematic studies on cactus in-depth in Korea are not sufficient, and the current consumption is reaching the limit compared to the production, which is increasing the burden on domestic cactus growers. On the other hand, cactus farms in Miyazaki Prefecture and Miyazaki Prefecture in Japan have established cacti as a special product in the form of processed foods [Lopez, PO and Burgos, RR: Canned prickly pear juice. Technologia De Alimentos , 8 , 237 (1973).

본 발명자들은 상기와 같은 점들을 감안하여 안출한 것으로, 선인장 열매 추출물의 일반 성분과 기초 성분을 분석하고, 상기 자료를 토대로 열매 고유의 색에 가장 가깝고 선인장 특유의 풋내와 풍미(無味)를 개선하기 위하여 pH에 따른 색소안정성을 분석하고 첨가되는 향, 당 및 산의 종류를 결정하고, 대식세포계 및 보체계에 대한 본 발명 선인장 열매 추출물의 면역활성강화 효과를 입증함으로써 본 발명을 완성하였다.The inventors of the present invention devised in view of the above points, to analyze the general and basic components of the cactus fruit extract, and based on the above data to close the fruit's intrinsic color and to improve the cactus-specific freshness and flavor In order to analyze the pigment stability according to pH and determine the type of flavor, sugar and acid to be added, the present invention was completed by demonstrating the effect of enhancing the immune activity of the cactus fruit extract of the present invention on macrophages and complement system.

따라서, 본 발명의 목적은 손바닥 선인장 열매에서 추출한 선인장 추출물을 제공함에 있다. 본 발명의 다른 목적은 상기 선인장 추출물을 유효성분으로 함유하는 면역활성강화제를 제공함에 있다.Accordingly, an object of the present invention is to provide a cactus extract extracted from the palm cactus fruit. Another object of the present invention to provide an immunoactive enhancer containing the cactus extract as an active ingredient.

본 발명의 상기 목적은 20∼30℃의 냉수, 70∼100℃의 열수, 메탄올 또는 에탄올을 사용하여 손바닥 선인장 열매 추출물을 추출하고; 상기 선인장 열매 추출물의 일반 성분 및 기초 성분을 분석하고; 본 발명 추출물을 함유하는 면역활성강화제의 제조공정 진행에 따른 색소의 안정성 저하에 의한 탈색문제를 극복하기 위하여 상기 본 발명 추출물의 pH에 따른 색소안정성을 분석하고, 선인장 특유의 풍미를 개선하기 위하여 첨가가능한 향, 당 및 산의 종류에 따른 본 발명 추출물에 대한 관능검사를 실시하여 상기 첨가물의 종류를 결정하고; 손바닥 선인장에 대하여 공지되지 않은 생리활성 효과, 즉 대식세포계 및 보체계에 대한 본 발명 선인장 추출물의 면역활성강화 효과를 규명함으로써 달성하였다.The above object of the present invention is to extract palm cactus fruit extract using cold water of 20-30 ℃, hot water of 70-100 ℃, methanol or ethanol; Analyzing the general and basic components of the cactus fruit extract; In order to overcome the problem of discoloration due to deterioration of the stability of the pigment according to the progress of the manufacturing process of the immunoactive enhancer containing the extract of the present invention, the pigment stability according to the pH of the extract of the present invention is analyzed and added to improve the flavor of the cactus Performing a sensory test on the extract of the present invention according to possible flavors, sugars and acids to determine the type of the additive; It was achieved by elucidating unknown physiological activity effects on the palm cactus, namely, the immunoactivating effect of the cactus extract of the present invention on macrophages and complement system.

이하, 본 발명의 구성을 상세하게 설명한다.EMBODIMENT OF THE INVENTION Hereinafter, the structure of this invention is demonstrated in detail.

도 1은 본 발명 손바닥 선인장 열매 냉수추출물을 추출하는 공정을 나타낸 공정도,1 is a process chart showing the process of extracting the present invention palm cactus fruit cold water extract,

도 2는 pH 변화에 따른 본 발명 손바닥 선인장 열매 냉수추출물의 상대 흡광도를 타나낸 그래프,Figure 2 is a graph showing the relative absorbance of the palm cactus fruit cold water extract of the present invention according to the pH change,

도 3은 본 발명 손바닥 선인장 열매 20℃ 냉수추출물 및 100℃ 열수추출물의 상대 흡광도를 나타낸 그래프,Figure 3 is a graph showing the relative absorbance of palm cactus fruit 20 ℃ cold water extract and 100 ℃ hot water extract of the present invention,

도 4는 본 발명 손바닥 선인장 열매 추출물의 대식세포 활성화도를 나타낸 그래프,Figure 4 is a graph showing the macrophage activation of the present invention palm cactus fruit extract,

도 5는 본 발명 손바닥 선인장 열매 추출물의 항보체 활성을 나타낸 그래프,5 is a graph showing the anti-complement activity of the present invention palm cactus fruit extract,

도 6은 본 발명 손바닥 선인장 열매 추출물을 함유하는 과립형 면역활성강화제의 사진도,Figure 6 is a photograph of the granular immunoactivator containing the present invention palm cactus fruit extract,

도 7은 본 발명 손바닥 선인장 열매 추출물을 함유하는 정제형 면역활성강화제의 사진도,Figure 7 is a photograph of a tablet-type immunoactive enhancer containing the present invention palm cactus fruit extract,

도 8은 본 발명 손바닥 선인장 열매 추출물을 함유하는 정제형 면역활성강화제의 사진도이다.Figure 8 is a photograph of a tablet-type immunoactivator containing the present invention palm cactus fruit extract.

본 발명 손바닥 선인장 열매 추출물은 물 또는 유기용매를 사용하여 추출한 것이다. 바람직하게는 물 또는 에탄올을 사용하여 추출한 것이다. 더 바람직하게는 20∼30℃의 냉수를 사용하여 추출한 것이다.Palm cactus fruit extract of the present invention is extracted using water or an organic solvent. Preferably extracted with water or ethanol. More preferably, it extracts using cold water of 20-30 degreeC.

본 발명 손바닥 선인장 열매 추출물은 면역활성강화 효과가 있는 기능성 식품 또는 식품의약으로 유용하게 사용될수 있다.Palm cactus fruit extract of the present invention can be usefully used as a functional food or food medicament having an effect of enhancing the immune activity.

또한, 본 발명 손바닥 선인장 열매 추출물을 유효성분으로 함유하는 면역활성강화제는 분말, 과립, 환 또는 정제로 제제화할수 있으며, 약학적으로 허용가능한 담체, 부형제, 분산제, 현탁화제 또는 안정화제를 함유할 수 있다.In addition, the immunoactive enhancer containing the palm cactus fruit extract of the present invention as an active ingredient may be formulated into a powder, granule, pill or tablet, and may contain a pharmaceutically acceptable carrier, excipient, dispersant, suspending agent or stabilizer. have.

이하, 본 발명의 구체적인 방법을 실시예 및 실험예를 들어 상세히 설명하고자 하지만 본 발명의 권리범위는 이들 실시예 및 실험예에만 한정되는 것은 아니다.Hereinafter, the specific method of the present invention will be described in detail with reference to Examples and Experimental Examples, but the scope of the present invention is not limited to these Examples and Experimental Examples.

실시예 1 : 손바닥 선인장 열매 추출물의 추출Example 1: Extraction of Palm Cactus Fruit Extract

시료로 사용되는 선인장의 생열매는 제주도 내 여러 농원에서 구입한 것을 사용하였다. 상기 구입한 선인장 생열매를 세척한 후, 20∼30℃의 증류수를 사용하여 선인장 냉수(cold water) 추출물을 얻었다. 70∼100℃의 증류수를 사용하여 선인장 열수(hot water) 추출물을 얻었다. 유기용매인 메탄올과 에탄올을 사용하여 선인장 메탄올추출물과 선인장 에탄올추출물을 얻었다. 상기 냉수, 온수 또는유기용매를 사용한 선인장 추출물은 당업자들이라면 용이하게 이해할 수 있는 통상적인 추출방법에 따라 추출하였으므로 그 세부적인 기술사항은 명기(明記)하지 않았다. 그러나, 본 발명은 일반적인 추출방법을 사용하였으나, 예를 들면 냉수추출물의 경우와 같이 메탄올 및 에탄올의 스크리닝(screening)을 거친 냉수추출물 분획을 사용하였다. 열수추출물, 메탄올추출물 및 에탄올추출물의 경우도 용매로 각각 열수, 메탄올, 에탄올을 사용하였다는 것을 제외하고는 상기 냉수 추출 방법과 동일하다. 상기 냉수추출물의 제조공정을 도 1에 나타내었다.Biofruit of cactus used as samples was purchased from various farms in Jeju Island. After washing the purchased cactus biofruit, cactus cold water extract was obtained using distilled water at 20 to 30 ° C. Cactus hot water extract was obtained using distilled water at 70-100 ° C. Cactus methanol extract and cactus ethanol extract were obtained using methanol and ethanol as organic solvents. Cactus extract using the cold water, hot water or organic solvent was extracted according to a conventional extraction method that can be easily understood by those skilled in the art, so the detailed technical details are not specified. However, the present invention used a general extraction method, for example, cold water extract fractions after screening of methanol and ethanol as in the case of cold water extract. Hot water extract, methanol extract and ethanol extract are also the same as the cold water extraction method except that hot water, methanol and ethanol are used as solvents, respectively. The cold water extract manufacturing process is shown in FIG. 1.

실시예 2 : 선인장 열매 추출물의 일반성분 분석Example 2 Analysis of General Components of Cactus Fruit Extract

A.O.A.C 공정법[Official Methods of Analysis, 15th ed., Association of Official Analytical Dhemists, Washington, D.C., USA. p.994 (1990)]에 따라 선인장 열매의 일반성분을 분석하였다. 즉, 수분 함량은 105℃ 상압가열건조법, 조지방 함량은 속슬레 추출법(Soxhlet extract method), 조섬유 함량은 H2SO4-NaOH 분석법, 조회분 함량은 직접회화법으로 측정하였다. 조단백질 함량은 세미마이크로 켈달(Semimicro kjeldahl)법으로 질소계수 6.25를 곱하여 산출하였다. 가용성 무질소물(nitrogen free extract)의 함량은 전체를 100%로 하여 수분, 조회분, 조지방, 조단백질 및 조섬유의 양을 뺀 값으로 표시하였다. 상기 가용성 무질소물이란 탄소, 수소 또는 산소의 3가지 성분으로 이루어진 물질로 탄수화물 즉 당류를 의미하며, 더욱 상세하게는 전분, 고무질, 당분, 점질물, 펙틴 또는 색소류를 모두 포함하는 명칭이다. 동결건조한 손바닥 선인장 열매 20∼30℃ 냉수추출물의 일반성분을 하기 표 1에 나타내었다.AOAC Process Methods [ Official Methods of Analysis , 15th ed., Association of Official Analytical Dhemists, Washington, DC, USA. p.994 (1990)], the general composition of cactus fruit was analyzed. That is, the moisture content was measured at 105 ° C atmospheric pressure drying, the crude fat content was determined by Soxhlet extract method, the crude fiber content was determined by H 2 SO 4 -NaOH analysis, and the ash content was measured by direct ashing. Crude protein content was calculated by multiplying the nitrogen coefficient by 6.25 using the Semimicro kjeldahl method. The content of soluble nitrogen free extract (nitrogen free extract) was expressed as 100% by subtracting the amount of moisture, crude ash, crude fat, crude protein and crude fiber. The soluble nitrogen-free substance is a substance consisting of three components of carbon, hydrogen or oxygen, and means carbohydrates or sugars, and more specifically, names including starch, rubbery, sugar, viscous substance, pectin or pigments. The general components of the freeze-dried palm cactus fruit 20 ~ 30 ℃ cold water extract is shown in Table 1.

손바닥 선인장 열매 냉수추출물의 일반성분Common Components of Palm Cactus Fruit Cold Water Extract 성분ingredient 함량(%)content(%) 수분moisture 9.469.46 조단백Crude protein 3.983.98 조지방Crude fat 1.481.48 조섬유Crude fiber 4.434.43 조회분View minutes 11.9511.95 가용성 무질소물Soluble Nitrogen 68.7068.70

상기 표 1에 나타낸 바와 같이, 손바닥 선인장의 일반성분 중 가장 많은 부분을 차지하는 주성분은 전체 일반성분에 대하여 68.70%를 차지한 가용성 무질소물이었다. 그 다음으로 조회분, 수분, 조섬유 순으로 그 함량은 각각 11.95%, 9.46%, 4.43%이었다.As shown in Table 1, the main component occupying the largest portion of the general components of palm cactus was soluble nitrogen-free, which occupies 68.70% of the total general components. After that, the contents were 11.95%, 9.46%, and 4.43%, respectively.

상기 손바닥 선인장 열매 냉수추출물과 동일한 방법으로 손바닥 선인장 열매 열수추출물, 에탄올추출물, 메탄올추출물에 대한 일반성분을 분석한 결과, 상기 냉수추출물의 결과와 거의 동일하였다.As a result of analyzing the general components of palm cactus fruit hot water extract, ethanol extract, methanol extract in the same manner as the palm cactus fruit cold water extract, it was almost the same as the result of the cold water extract.

실시예 3 : 손바닥 선인장 열매 추출물내 식이섬유 함량, pH, 최대흡광도 측정Example 3 Measurement of Dietary Fiber Content, pH, and Maximum Absorbance in Palm Cactus Fruit Extract

A.O.A.C. 공정법[Official Methods of Analysis, 16th ed., Association of Official Analytical Dhemists, Washington, D.C., USA. ch.12 p.7, ch.14 p.70(1995)]을 참조하여 동결건조된 분말시료 1.0g에 0.08M 포스페이트 버퍼(pH 6.0) 50㎖을 첨가하였다. 상기 용액의 pH를 6.0±0.2가 되도록 조절하였다. 상기 용액에 열에 안정한 α-아밀라제인 테르마밀(Termamyl)액 0.1㎖을 첨가한 후 95℃에서 15분간 가열하고, 100℃에서 15분간 더 가열하였다. 상기 반응용액을 실온에서 방냉시킨 후 0.275N NaOH 용액으로 pH를 7.5±0.1로 조정하고 프로테아제 용액 0.1㎖을 첨가하였다. 상기 용액을 다시 60℃ 진탕 항온기에서 30분간 반응시켜 방냉한 후 0.275N HCl 용액을 가하여 pH를 4.0∼4.6으로 조절하였다. 상기 용액에 0.3㎖ 아밀로글루코시다제(amyloglucosidase)를 첨가하고, 다시 60℃ 진탕 항온기에 넣고 30 분간 반응시켰다. 0.5g의 셀라이트(celite)를 조립유리프릿(coarse glass-frit)에 담아 중량(시료 무첨가시의 중량)을 측정한 후 반응을 완료시킨 상기 효소 혼합액을 여과시켰다. 그후, 상기 여과액을 증류수, 95% 에탄올 및 아세톤 각각 10㎖로 2회 세척하였다. 상기 여과액에 증류수를 가하여 100g이 되도록 한 후 60℃의 에탄올 400㎖을 가하여 실온에서 60분간 방치하였다. 상기 방법과 같이 조립유리프릿으로 침전혼합물을 여과하였다. 그후, 78% 에탄올 20㎖로 3회 세척하고, 95% 에탄올, 아세톤 각각 10㎖로 2회 세척하였다. 여과 후 침전물이 담긴 용기를 105℃의 건조기에서 하루 동안 건조시킨 후 데시케이터(desiccator)에서 방냉한 후의 중량을 측정하였다. 두 개의 시료 중 하나는 켈달법에 의한 단백질 정량에 사용하였고, 나머지 하나는 525℃에서 5시간 회화시킨 후 회분 정량에 사용하였다. 하기 수학식 1에 따라서 가용성 식이섬유 (Soluble Dietary Fiber, SDF)의 함량을 산출하였다.AOAC Process Methods [ Official Methods of Analysis , 16th ed., Association of Official Analytical Dhemists, Washington, DC, USA. ch. 12 p. 7, ch. 14 p. 70 (1995)] was added 50 ml of 0.08 M phosphate buffer (pH 6.0) to 1.0 g of the lyophilized powder sample. The pH of the solution was adjusted to 6.0 ± 0.2. To the solution was added 0.1 ml of a thermally stable α-amylase termamyl solution, followed by heating at 95 ° C. for 15 minutes and further heating at 100 ° C. for 15 minutes. After the reaction solution was allowed to cool at room temperature, the pH was adjusted to 7.5 ± 0.1 with 0.275N NaOH solution and 0.1 ml of protease solution was added thereto. The solution was reacted again for 30 minutes in a 60 ° C shaking incubator and allowed to cool. Then, the pH was adjusted to 4.0-4.6 by adding 0.275N HCl solution. 0.3ml amyloglucosidase was added to the solution, which was then placed in a 60 ° C shaker and allowed to react for 30 minutes. 0.5 g of celite was placed in coarse glass-frit to measure the weight (when no sample was added), and then the enzyme mixture was completed. The filtrate was then washed twice with 10 ml of distilled water, 95% ethanol and acetone each. Distilled water was added to the filtrate to make 100 g, and 400 ml of 60 ° C. ethanol was added thereto, and the mixture was left at room temperature for 60 minutes. The precipitate mixture was filtered through a granulated glass frit as described above. Then, washed three times with 20 ml of 78% ethanol, twice with 10 ml of 95% ethanol, acetone each. After filtration, the vessel containing the precipitate was dried in a dryer at 105 ° C. for one day, and then weighed after cooling in a desiccator. One of the two samples was used for protein quantification by the Kjeldahl method, and the other was used for ash quantification after incubating for 5 hours at 525 ° C. The content of soluble dietary fiber (Soluble Dietary Fiber, SDF) was calculated according to Equation 1 below.

한편, 불용성 식이섬유(Insoluble Dietary Fiber, IDF)의 함량을 측정하기 위하여, 조립유리프릿으로 침전여과물을 여과한 후 증류수, 95% 에탄올 및 아세톤 각각 10㎖로 2회 세척하는 단계까지는 상기 가용성 식이섬유의 함량 분석에서와 동일한 방법을 반복하였다. 상기 침전단계 직후, 침전물이 담긴 용기를 105℃의 건조기에서 하루 동안 건조시킨 후 데시케이터에서 방냉한 후의 중량을 측정하였다. 두 개의 시료 중 하나는 켈달법에 의한 단백질 정량에 사용하였고, 나머지 하나는 525℃에서 5시간 회화시킨 후 회분 정량에 사용하였다. 하기 수학식 2에 따라서 불용성 식이섬유의 함량을 산출하였다.On the other hand, in order to measure the content of insoluble dietary fiber (Insoluble Dietary Fiber, IDF), the precipitated filtrate was filtered with a glass frit and then washed twice with 10 ml of distilled water, 95% ethanol and acetone. The same method was repeated as in the analysis of the fiber content. Immediately after the precipitation step, the vessel containing the precipitate was dried in a dryer at 105 ° C. for one day, and then weighed after cooling in a desiccator. One of the two samples was used for protein quantification by the Kjeldahl method, and the other was used for ash quantification after incubating for 5 hours at 525 ° C. The content of insoluble dietary fiber was calculated according to Equation 2 below.

산출한 SDF 및 IDF 수치로부터 하기 수학식 3에 의거하여 총식이섬유 함량(Total Dietary Fiber, TDF)을 산출하였다.The total dietary fiber content (Total Dietary Fiber, TDF) was calculated based on Equation 3 from the calculated SDF and IDF values.

구입한 농원별 손바닥 선인장 열매 냉수추출물의 수용성 식이섬유 함량과 불용성 식이섬유 함량을 합산한 총식이섬유 함량을 구하고, pH를 측정한 후, 535nm에서 적색색소인 베타라인의 최대 흡광도를 측정하였다. 그 결과를 하기 표 2에 나타내었다.The total dietary fiber content obtained by adding the water-soluble dietary fiber content and the insoluble dietary fiber content of the palm cactus fruit cold water extract purchased by each plant was measured, and the pH was measured, and then the maximum absorbance of the betaline, the red pigment, was measured at 535 nm. The results are shown in Table 2 below.

손바닥 선인장 열매의 냉수추출물내 총식이섬유 함량, pH, 최대흡광도 측정Determination of Total Dietary Fiber, pH, and Maximum Absorption in Cold Water Extracts of Palm Cactus Fruits 시료sample 색소(535nm에서의 최대흡광도)Pigmentation (maximum absorbance at 535 nm) pHpH 총식이섬유 함량(%)Total dietary fiber content (%) S-1S-1 0.1160.116 4.434.43 41.441.4 S-2S-2 0.2720.272 4.054.05 43.143.1 S-3S-3 0.5260.526 4.144.14 30.130.1 S-1, S-2, S-3는 구입한 농원을 구별하기 위하여 임의로 명명한 것이며, 상기 시료는 모두 냉수추출물이다.S-1, S-2, and S-3 are arbitrarily named to distinguish purchased farms, and all the samples are cold water extracts.

상기 표 2에 나타낸 바와 같이, 식이섬유의 함량은 시료를 구입한 농장에 따라 S-1과 S-2 시료가 S-3 시료보다 10% 이상 많이 함유되어 있었다. 각 시료의 pH는 S-1>S-3>S-2 순으로 높았다. 최대흡광도는 레드 비트(red beet)와 동일한 영역인 535nm에서 최대흡광도를 나타내었으며, S-3의 시료는 270nm에서도 흡수 피크가 나타났다. 또한, S-1 또는 S-2 시료보다 S-3 시료가 535nm에서 훨씬 높은 흡광도를 나타내었다. 가공 공정에서 S-3 시료가 색소 안정성이 뛰어난 점으로 미루어 높은 흡광도와 UV영역인 270nm에서의 흡수 피크가 색소안정성에 관여하는 것으로 추정되었다.As shown in Table 2, the content of dietary fiber contained more than 10% S-1 and S-2 samples than S-3 samples, depending on the farm where the sample was purchased. The pH of each sample was as high as S-1> S-3> S-2. The maximum absorbance showed the maximum absorbance at 535 nm, the same region as the red beet, and the sample of S-3 showed an absorption peak even at 270 nm. In addition, the S-3 sample showed much higher absorbance at 535 nm than the S-1 or S-2 sample. In view of the fact that the S-3 sample had excellent pigment stability in the processing step, it was estimated that the absorbance peak at 270 nm, which is high absorbance and UV region, was involved in the dye stability.

실시예 4 : 손바닥 선인장 열매 추출물내 색소의 안정성 분석Example 4 Analysis of Stability of Pigment in Palm Cactus Fruit Extract

선인장 열매 추출물의 열처리 및 pH 변화에 따른 적색 색소의 안정성을 분석하기 위하여 본 발명 냉수추출물의 시료액의 pH를 4 내지 12까지 변화시키면서 535nm에서의 흡광도 변화를 측정하고, 냉수추출 조건과 열수추출 조건시의 흡광도 변화를 측정하였다. 상기 pH 변화실험에서 상대 흡광도(%)는 pH 4.15에서의 흡광도를 100으로 가정했을 때 각 pH 에서의 흡광도를 비교치로 환산하였다. 그 결과를 도 2에 나타내었다. 추출조건 실험에서는 20℃ 냉수추출물의 흡광도를 100으로 가정했을 때 100℃ 열수추출물의 흡광도를 비교치로 환산하였다. 그 결과를 도 3에 나타내었다.In order to analyze the stability of the red pigment according to the heat treatment and pH change of the cactus fruit extract, the change of absorbance at 535 nm was measured while changing the pH of the sample solution of the cold water extract of the present invention to 4-12, and the cold water extraction condition and the hot water extraction condition The absorbance change at the time was measured. In the pH change experiment, the relative absorbance (%) was converted into a comparison value of the absorbance at each pH when the absorbance at pH 4.15 was assumed to be 100. The results are shown in FIG. In the extraction condition experiment, when the absorbance of 20 ℃ cold water extract was assumed to be 100, the absorbance of 100 ℃ hot water extract was converted into a comparative value. The results are shown in FIG.

도 2에 도시된 바와 같이 pH가 알칼리 쪽으로 갈수록 흡광도는 감소하여 pH 8에서는 상대흡광도가 50% 이하로 떨어졌으며, 도 3에 도시된 바와 같이 열수추출물의 흡광도가 냉수추출물에 비해 20% 이하까지 낮았다. 상기로 부터 선인장 열매의 적색 색소는 산성조건에서는 안정되나 알칼리 조건에서는 극히 불안정하며, 열에도 약하여 고온에서의 열수 추출은 바람직하지 않음을 알 수 있었다.As shown in FIG. 2, the absorbance decreases toward the alkali side, so the relative absorbance drops to 50% or less at pH 8, and the absorbance of the hot water extract is lower than 20% compared to the cold water extract as shown in FIG. . From the above, the red pigment of the cactus fruit is stable under acidic conditions, but extremely unstable under alkaline conditions, and also weak in heat, and thus it is found that hot water extraction at high temperature is not preferable.

실시예 5 : 향, 당 또는 산의 종류에 따른 손바닥 선인장 열매 추출물의 관능검사Example 5 Sensory Evaluation of Palm Cactus Fruit Extract According to Flavor, Sugar or Acid Type

실험예 1: 향(flavor) 종류에 따른 손바닥 선인장 열매 추출물의 관능검사Experimental Example 1: Sensory Evaluation of Palm Cactus Fruit Extract According to Flavor Type

본 발명 손바닥 선인장 열매 추출물의 적색색소 및 점성에 가장 적합한 다양한 향, 즉 라즈베리향, 블랙베리향, 수박향, 아세로라향, 오디향, 오미자향, 패션후르츠향, 혼합과일향, 딸기향, 머루향, 블루베리향, 앨더베리향, 자두향과 포도향에 대하여 관능검사를 실시하였다. 상기 추출물로는 본 발명 선인장 열매 냉수추출물을 사용하였다. 그 결과, 포도향과 패션후르츠향이 가장 우수하였다. 따라서, 본 발명 선인장 열매 추출물을 유효성분으로 함유하는 면역활성강화제에는 포도맛과 패션후르츠향이 코팅된 혼합 향을 사용하였다. 상기 관능검사 결과를 하기 표 3에 기재하였다. 각 관능검사는 변형된 5점 계산법으로 실시하였으며, 난괴법(randomized complete block design)을 이용하여 평가하였다. 평가된 점수는 1(+)로 갈수록 특성의 강도가 약해지며 5(+++++)로 갈수록 강해짐을 나타낸다.Various flavors that are best suited to the red pigment and viscosity of the palm cactus fruit extract of the present invention, that is, raspberry flavor, blackberry flavor, watermelon flavor, acerola flavor, mulberry flavor, scented flavor, passion fruit flavor, mixed fruit flavor, strawberry flavor, berry flavor Sensory tests were conducted for the blueberry, alderberry, plum and grape flavors. Cactus fruit cold water extract of the present invention was used as the extract. As a result, grape and passion fruit were the best. Accordingly, the present invention used a mixed flavor coated grape flavor and fashion fruit flavor as an immunoactive enhancer containing the cactus fruit extract as an active ingredient. The sensory test results are shown in Table 3 below. Each sensory test was performed using a modified 5-point calculation method and evaluated using a randomized complete block design. The scores indicate that the strength of the property is weaker as 1 (+) and stronger as 5 (+++++).

향 종류에 따른 본 발명 손바닥 선인장 열매 추출물의 관능검사Sensory Evaluation of Palm Cactus Fruit Extract of the Present Invention According to Flavor incense 점수score 라즈베리향Raspberry flavor ++++ 블랙베리향Blackberry flavor ++ 수박향Watermelon flavor ++ 아세로라향Acerola flavor ++ 오디향Audi ++++++ 오미자향Schisandra flavor ++ 패션후르츠향Passion fruit flavor ++++++++++ 혼합과일향Mixed Fruit Flavor ++++++++ 딸기향Strawberry flavor ++ 머루향Aroma ++++ 블루베리향Blueberry flavor ++++ 앨더베리향Alderberry flavor ++++++ 자두향Plum flavor ++++ 포도향Grape ++++++++++

실험예 2: 당(sugar) 종류에 따른 손바닥 선인장 열매 추출물의 관능검사Experimental Example 2: Sensory Evaluation of Palm Cactus Fruit Extract According to Sugar Types

본 발명 손바닥 선인장 열매 추출물에 가장 적합한 단맛을 부여하기 위하여 당 종류를 달리하여 관능검사를 실시하였다. 본 실험예에서는 당류로자일리톨(xylitol), 포도당, 과당, 유당 및 스테비오사이드(stevioside)를 사용하였다. 상기 추출물로는 본 발명 선인장 열매 냉수추출물을 사용하였다. 그 결과, 자일리톨이 가장 우수하였으며 그 다음으로는 유당이 우수하였다. 상기 관능검사 결과를 하기 표 4에 기재하였다. 각 관능검사는 변형된 5점 계산법으로 실시하였으며, 난괴법을 이용하여 평가하였다. 평가된 점수는 1(+)로 갈수록 특성의 강도가 약해지며 5(+++++)로 갈수록 강해짐을 나타낸다.In order to give the most suitable sweetness to the palm cactus fruit extract of the present invention, the sensory test was carried out by varying the sugar type. In the present experimental example, saccharide xylitol, glucose, fructose, lactose and stevioside were used. Cactus fruit cold water extract of the present invention was used as the extract. As a result, xylitol was the best, followed by lactose. The sensory test results are shown in Table 4 below. Each sensory test was carried out using a modified five-point calculation method, and evaluated using an ingot method. The scores indicate that the strength of the property is weaker as 1 (+) and stronger as 5 (+++++).

당 종류에 따른 본 발명 손바닥 선인장 열매 추출물의 관능검사Sensory Test of Palm Cactus Fruit Extract of the Present Invention According to Sugar Types Party 점수score 자일리톨Xylitol ++++++++++ 포도당glucose ++++ 과당fruit sugar ++++ 유당Lactose ++++++++ 스테비오사이드Stevioside ++++++

실험예 3 : 산(acid) 종류에 따른 손바닥 선인장 열매 추출물의 관능검사Experimental Example 3 Sensory Test of Palm Cactus Fruit Extracts According to Acid Type

본 발명 손바닥 선인장 열매 추출물에 가장 적합한 신맛을 부여하기 위하여 산 종류를 달리 하여 관능검사를 실시하였다. 본 실험예에서는 산으로 함수구연산, 무수구연산, 사과산, 젖산, 비타민 C, 주석산, 푸마르산, 호박산을 사용하였다. 상기 추출물로는 본 발명 선인장 열매 냉수추출물을 사용하였다. 그 결과, 사과산과 비타민 C가 가장 우수하였다. 상기 관능검사 결과를 하기 표 5에 기재하였다. 각 관능검사는 변형된 5점 계산법으로 실시하였으며, 난괴법을 이용하여 평가하였다. 평가된 점수는 1(+)로 갈수록 특성의 강도가 약해지며 5(+++++)로 갈수록 강해짐을 나타낸다.In order to give the best sour taste to the palm cactus fruit extract of the present invention, the sensory test was carried out by varying the acid type. In this experimental example, hydrous citric acid, citric anhydride, malic acid, lactic acid, vitamin C, tartaric acid, fumaric acid, and succinic acid were used as the acid. Cactus fruit cold water extract of the present invention was used as the extract. As a result, malic acid and vitamin C were the best. The sensory test results are shown in Table 5 below. Each sensory test was carried out using a modified five-point calculation method, and evaluated using an ingot method. The scores indicate that the strength of the property is weaker as 1 (+) and stronger as 5 (+++++).

산 종류에 따른 본 발명 손바닥 선인장 열매 추출물의 관능검사Sensory Test of Palm Cactus Fruit Extract of the Present Invention According to Acid Type mountain 점수score 함수구연산Function ++++++ 무수구연산Anhydrous Citric Acid ++++++ 사과산Malic acid ++++++++++ 젖산Lactic acid ++++ 비타민 CVitamin c ++++++++++ 주석산Tartaric acid ++ 푸마르산Fumaric acid ++ 호박산Succinic acid ++

실시예 6 : 본 발명 손바닥 선인장 열매 추출물의 생리활성 효과 측정Example 6 Measurement of the Biological Activity of the Palm Cactus Fruit Extract of the Present Invention

실험예 4 : 대식세포(macrophage) 활성화도 측정Experimental Example 4 Measurement of Macrophage Activation

상기 실시예 1에서 제조한 손바닥 선인장 열매의 냉수추출물, 열수추출물, 메탄올추출물, 에탄올추출물을 각각 생리식염수에 용해시켜 100㎍/㎖의 추출물 테스트용액을 제조하였다. 5∼8 주령 웅성 ICR 마우스의 복강 내에 티오글리콜레이트(thioglycollate) 배양액 1㎖을 주입한 후 48∼72 시간 내에 헤페즈(Hepes), 페니실린/스트렙토마이신 및 암포테리신 B(amphotericin B)를 함유한 RPMI-1640 배양액으로 세척하고, 마우스 복강에서 대식세포를 채취하였다. 상기 채취된 대식세포를 RPMI-1640 배양액으로 2회 세척하고 세포수가 1×106개/㎖이 되도록 RPMI-1640 배양액에 재분산시켰다. 상기 분산액을 96-웰 플레이트의 각 웰에 180㎕씩 분주한 후, 37℃, 5% CO2항온배양기에서 2시간 동안 배양하였다.Cold water extract, hot water extract, methanol extract and ethanol extract of Palm Cactus fruit prepared in Example 1 were dissolved in physiological saline, respectively, to prepare an extract test solution of 100 µg / ml. RPMI containing Hepes, penicillin / streptomycin and amphotericin B within 48-72 hours after injecting 1 ml of a thioglycollate culture into the abdominal cavity of 5-8 week old male ICR mice Washed with -1640 culture and macrophages were harvested from mouse abdominal cavity. The harvested macrophages were washed twice with RPMI-1640 culture and redispersed in RPMI-1640 culture so that the cell number was 1 × 10 6 cells / ml. The dispersion was dispensed into each well of a 96-well plate 180 μl, and then incubated for 2 hours in a 37 ° C., 5% CO 2 incubator.

대식세포가 각 웰에서 단층(monolayer)을 형성하면 비부착세포를 RPMI-1640배양액으로 두 번 세척하여 제거한 후, 10% FBS(fetal bovine serum)을 함유한 RPMI-1640 배양액을 각 웰에 180㎕씩 분주하고, 여기에 상기에서 제조한 추출물 테스트 용액 20㎕을 각각 가하여 37℃, 5% CO2항온배양기에서 24 시간 배양하여 대식세포를 활성화시켰다.When macrophages form monolayers in each well, non-adherent cells are washed twice with RPMI-1640 culture medium and then removed, followed by 180 μl of RPMI-1640 medium containing 10% FBS (fetal bovine serum) in each well. Each aliquot was added, and 20 μl of the extract test solution prepared above was added thereto, followed by incubation for 24 hours at 37 ° C. and a 5% CO 2 incubator to activate macrophages.

상기 활성화된 대식세포의 단층에 0.1% 트리톤 X-100 25㎕를 가하여 대식세포의 세포막을 용해시켜 이때 분비되는 리소좀(lysosome)의 산성포스파타아제(acid phosphatase)의 기질로서 10mM ρ-니트로페닐 포스페이트 150㎕를 0.1M 구연산 버퍼 50㎕와 같이 첨가하여 1시간 동안 산성 상태에서 반응시키고, 0.2M 붕산염 버퍼를 가하여 반응을 정지시킨 후, ELISA READER(Bio-Rad 3550-UV)로 405㎚에서 흡광도를 측정하였다. 상기 방법으로 측정한 본 발명 각 추출물의 흡광도를 음성대조군인 생리식염수의 흡광도를 기준으로 비교한 값을 대식세포 상대 활성화도로 나타내었다[Suzuki 등, Effect of orally administered β-glucan on macrophage function in mice.Int. Soc. Immunopharmac.12, 675 (1990)]. 그 결과를 도 4에 나타내었다.25 μl of 0.1% Triton X-100 was added to the monolayer of the activated macrophages to dissolve the cell membranes of the macrophages. At this time, 10 mM ρ-nitrophenyl phosphate was used as a substrate of the acid phosphatase of lysosomes. 150 μl was added together with 50 μl of 0.1 M citric acid buffer to react in acidic condition for 1 hour, and the reaction was stopped by adding 0.2 M borate buffer, followed by absorbance at 405 nm with ELISA READER (Bio-Rad 3550-UV). Measured. Comparison of the absorbance of each extract of the present invention measured by the above method based on the absorbance of physiological saline, a negative control group, was shown as a macrophage relative activation [Suzuki et al., Effect of orally administered β-glucan on macrophage function in mice. Int. Soc. Immunopharmac. 12, 675 (1990). The results are shown in FIG.

본 발명 손바닥 선인장 열매 추출물의 대식세포 상대 활성도는 100㎍/㎖의 농도에서 열수추출물, 냉수추출물, 메탄올추출물 및 에탄올추출물이 각각 160%, 199%, 111% 및 201%이었다. 상기 결과로부터 고분자 획분중에서는 냉수추출물이, 저분자 획분중에서는 에탄올추출물이 대식세포를 활성화 시키는 효과가 우수함을 알 수 있었다. 따라서, 상기 본 발명 손바닥 선인장 열매 추출물이 200% 내외의높은 대식세포 상대 활성도를 나타내는 것으로 보아 본 발명 손바닥 선인장 열매 추출물은 면역활성 효과가 있음을 알 수 있었다.The macrophage relative activity of the palm cactus fruit extract of the present invention was 160%, 199%, 111% and 201% of hot water extract, cold water extract, methanol extract and ethanol extract at a concentration of 100 µg / ml, respectively. From the above results, it was found that the cold water extract in the polymer fraction and the ethanol extract in the low molecular fraction were excellent in activating the macrophages. Therefore, the palm cactus fruit extract of the present invention showed a high macrophage relative activity of about 200%, and thus it was found that the palm cactus fruit extract of the present invention has an immunological activity.

실험예 5 : 항보체 활성(anti-complement activity) 측정Experimental Example 5: measurement of anti-complement activity

항보체 활성은 메이어(Mayer)법을 이용하여 시료에 의한 보체 소비(complement consumption)후 남은 보체에 의한 적혈구 용혈 정도에 근거를 둔 보체고정시험(complement fixation test)으로 측정하였다. 즉, 정상인의 혈청과 2% 겔라틴, 3mM Ca++, 10mM Mg++이 함유된 GVB++(gelatin veronal buffered saline, pH 7.4)와 3차 증류수에 용해한 본 발명 선인장 열매 추출물을 각각 50㎕씩 혼합하여 37℃에서 30분간 1차 반응시킨 후 이 반응액에 GVB++350㎕를 가한 후 이를 10∼160배로 연속 희석하였다. 여기에 다시 GVB++750㎕를 가한 후 양의 감작 적혈구(EA cell) 250㎕을 가하고 37℃에서 60분간 2차 반응시킨 후 PBS(phosphated buffered saline, pH 7.4) 2.5㎖을 첨가하고 반응을 정지시켰다. 상기 반응액을 2500rpm에서 10분간 원심분리하여 얻어진 상등액의 흡광도를 412nm에서 측정하였다. 항보체 활성은 NHS, 버퍼, 시료 대신 탈이온수(deionized water)만을 반응시킨 대조군의 총보체 용혈(50% total complement hemolysis, TCH50%)에 대한 저지율(inhibition of 50% total complement hemolysis, ITCH50%)로 나타내었다[Kabat 등, Complement and complement fixation. In ExperimentalImmunology. Charles C Thomas Publisher. Ilinois (1964)]. 그 결과를 도 5에 나타내었다.Anti-complement activity was measured by complement fixation test based on the degree of erythrocyte hemolysis by complement remaining after complement consumption by the sample using the Meyer method. That is, 50 μl of the cactus fruit extract of the present invention dissolved in serum, 2% gelatin, 3 mM Ca ++ , 10 mM Mg ++ GVB ++ (gelatin veronal buffered saline, pH 7.4) and tertiary distilled water, respectively. Each mixture was first reacted at 37 ° C. for 30 minutes, and then 350 μl of GVB ++ was added to the reaction solution, which was serially diluted 10-160 times. After adding 750 μl of GVB ++, 250 μl of positive sensitized erythrocytes (EA cells) were added thereto, followed by secondary reaction at 37 ° C. for 60 minutes, and then 2.5 ml of PBS (phosphated buffered saline, pH 7.4) was added to stop the reaction. I was. The absorbance of the supernatant obtained by centrifuging the reaction solution at 2500 rpm for 10 minutes was measured at 412 nm. Anti-complement activity was inhibited by 50% total complement hemolysis (TCH 50 %) of the control group reacted only with deionized water instead of NHS, buffer, and sample (inhibition of 50% total complement hemolysis, 50 % ITCH). Kabat et al., Complement and complement fixation. In Experimental Immunology. Charles C Thomas Publisher. Ilinois (1964). The results are shown in FIG.

본 발명 손바닥 선인장 열매 추출물의 항보체 활성은 최대 항보체 활성을 100%로 보았을 때 1000㎍/㎖의 농도에서 냉수추출물, 열수추출물 및 에탄올추출물이 각각 70%, 50%, 및 63%로 냉수추출물에서 가장 높았다.Anti-complement activity of palm cactus fruit extract of the present invention is cold water extract, hot water extract and ethanol extract 70%, 50%, and 63%, respectively, at a concentration of 1000 µg / ml when the maximum anticomplement activity is 100%. Was the highest at.

실시예 7 : 본 발명 손바닥 선인장 열매 추출물을 유효성분으로 함유하는 면역활성강화제의 제조Example 7 Preparation of an Immunostimulating Agent Containing Palm Fructus Fruit Extract of the Present Invention as an Active Ingredient

상기 실시예 1 내지 6의 결과를 바탕으로 본 발명 선인장 열매 추출물을 유효성분으로 함유하는 면역활성강화제를 제조하였다. 본 발명에 따른 과립형 면역활성강화제의 한 예에 대한 성분과 그 함량을 하기 표 6에 나타내었다. 한편, 상기 과립형 면역활성강화제의 사진도를 도 6에 나타내었다.Based on the results of Examples 1 to 6, an immunoactive enhancer was prepared containing the present invention cactus fruit extract as an active ingredient. The components and contents of one example of the granular immunostimulating agent according to the present invention are shown in Table 6 below. On the other hand, a photographic view of the granular immunoactivator is shown in FIG.

성분ingredient 함량content 손바닥 선인장열매 추출물Palm Cactus Fruit Extract 33.3333.33 유당Lactose 33.3333.33 포도맛 분말Grape powder 2.222.22 비타민 CVitamin c 3.63.6 (비소성)패각 석화분(Ca 35%)(Non-fired) Shell Petrified Powder (Ca 35%) 3.63.6 DL-사과산DL-apple mountain 1.81.8 패션후르트향코튼Passion fruit flavored cotton 0.920.92 L-카르니틴L-carnitine 0.60.6 타우린Taurine 0.60.6 합계Sum 100.0100.0

본 발명에 따른 정제형 면역활성강화제의 한 예에 대한 성분과 그 함량을 하기 표 7에 나타내었다. 한편, 상기 정제형 면역활성강화제의 사진도를 도 7에 나타내었다. 또 다른 정제형 면역활성강화제의 사진도를 도 8에 나타내었다.The components and the contents of one example of the tablet-type immunoactivator according to the present invention are shown in Table 7 below. On the other hand, a photographic view of the tablet immunoactivator is shown in FIG. 8 is a photograph of another tablet immunopotentiator.

성분ingredient 함량content (비소성)패각 석화분(Ca 35%)(Non-fired) Shell Petrified Powder (Ca 35%) 33.3333.33 포도맛 분말Grape powder 15.3315.33 (무수)결정포도당(Anhydrous) crystalline glucose 15.015.0 손바닥 선인장열매 추출물Palm Cactus Fruit Extract 12.312.3 자일리톨Xylitol 9.69.6 젖산Lactic acid 9.09.0 비타민 CVitamin c 1.531.53 타우린Taurine 1.531.53 스테아린마그네슘Stearin magnesium 0.9850.985 (무수)구연산(Anhydrous) citric acid 0.90.9 산화아연Zinc oxide 0.240.24 패션후르트향코튼Passion fruit flavored cotton 0.240.24 스테비오사이드Stevioside 0.0150.015 합계Sum 100.0100.0

이상, 상기 실시예 및 실험예에서 설명한 바와 같이 본 발명 손바닥 선인장 열매 추출물은 대식세포계 및 보체계에 대한 면역활성강화 작용이 있으므로 이를 유효성분으로 함유하는 면역활성강화제는 각종 면역질환의 예방 및 치료와 관련한 기능성 식품 및 식품의약 산업상 매우 유용한 발명인 것이다.As described above, the palm cactus fruit extract of the present invention, as described in Examples and Experimental Examples, has an immune activity enhancing effect on the macrophage and complement system, and thus an immunoactive enhancer containing the same as an active ingredient relates to the prevention and treatment of various immune diseases. It is a very useful invention in the functional food and food and pharmaceutical industry.

Claims (4)

물 또는 유기용매에 의해 추출되고, 대식세포계(macrophage) 및 보체계(complement system)의 활성을 증가시켜 면역활성을 강화하는 것을 특징으로 하는 손바닥 선인장(Opuntia ficus-indica) 열매 추출물.Extracted by water or an organic solvent, Opuntia ficus-indica fruit extract, characterized in that to enhance the immune activity by increasing the activity of the macrophage and complement system (complement system). 제 1 항에 있어서, 상기 물은 20∼30℃의 냉수(cold water)인 것을 특징으로 하는 손바닥 선인장 열매 추출물.The palm cactus fruit extract according to claim 1, wherein the water is cold water at 20 to 30 ° C. 제 1 항에 있어서, 상기 유기용매는 에탄올인 것을 특징으로 하는 손바닥 선인장 열매 추출물.The palm cactus fruit extract according to claim 1, wherein the organic solvent is ethanol. 제 1 항 기재의 손바닥 선인장 열매 추출물을 유효성분으로 함유함을 특징으로 하는 면역활성강화제.An immunoactivator, characterized in that it contains the palm cactus fruit extract of claim 1 as an active ingredient.
KR1020010030869A 2001-06-01 2001-06-01 Opuntia ficus-indica fruit extract and immuno-activating agent comprising it as an effective component KR20020092021A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010030869A KR20020092021A (en) 2001-06-01 2001-06-01 Opuntia ficus-indica fruit extract and immuno-activating agent comprising it as an effective component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010030869A KR20020092021A (en) 2001-06-01 2001-06-01 Opuntia ficus-indica fruit extract and immuno-activating agent comprising it as an effective component

Publications (1)

Publication Number Publication Date
KR20020092021A true KR20020092021A (en) 2002-12-11

Family

ID=27707586

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010030869A KR20020092021A (en) 2001-06-01 2001-06-01 Opuntia ficus-indica fruit extract and immuno-activating agent comprising it as an effective component

Country Status (1)

Country Link
KR (1) KR20020092021A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100452057B1 (en) * 2002-03-16 2004-10-08 고영환 Method for preparation of aseptic fruit powder of Opuntia ficus-india var. saboten and functional foods comprising the fruit powder prepared using the same
DE112008002948T5 (en) 2007-11-06 2010-11-25 Finzelberg Gmbh & Co. Kg Extract preparation of Opuntia ficus indica
KR101218355B1 (en) * 2009-04-29 2013-01-03 전라남도 Preparation method of betacyanin from tungtungmadi
KR20190008714A (en) 2017-07-17 2019-01-25 한국식품연구원 Method for manufacturing fruit powder of Opuntia spp.and fruit powder of Opuntia spp.prepared therefrom

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100452057B1 (en) * 2002-03-16 2004-10-08 고영환 Method for preparation of aseptic fruit powder of Opuntia ficus-india var. saboten and functional foods comprising the fruit powder prepared using the same
DE112008002948T5 (en) 2007-11-06 2010-11-25 Finzelberg Gmbh & Co. Kg Extract preparation of Opuntia ficus indica
US10857193B2 (en) 2007-11-06 2020-12-08 Finzelberg Gmbh & Co. Kg Extract formulation of Opuntia ficus indica
KR101218355B1 (en) * 2009-04-29 2013-01-03 전라남도 Preparation method of betacyanin from tungtungmadi
KR20190008714A (en) 2017-07-17 2019-01-25 한국식품연구원 Method for manufacturing fruit powder of Opuntia spp.and fruit powder of Opuntia spp.prepared therefrom

Similar Documents

Publication Publication Date Title
US11219653B2 (en) Composition for enhancing immunity, containing ginseng berry polysaccharides
KR20120139644A (en) Compound comprising extracts or fractions of chrysanthemum boreale makino having anti-inflammation activity
US8673376B2 (en) Polyphenol-containing composition for oral administration or external use and use of same
KR101738664B1 (en) Method for producing honeyed ginseng snack coated with Pueraria lobata starch solution
JP5632054B2 (en) Composition mainly composed of polysaccharide having immunomodulating function
KR20020092021A (en) Opuntia ficus-indica fruit extract and immuno-activating agent comprising it as an effective component
KR102294288B1 (en) Polysaccharide fraction isolated from Nelumbo nucifera leaf with immune-enhancing activity and method for producing the same
KR101620275B1 (en) Brown algae-derived mixed composition and preparation method thereof
KR101692889B1 (en) Composition comprising an extract or a fraction of Daphne kamtschatica for preventing or treating inflammatory diseases
KR101604347B1 (en) Pharmaceutical composition comprising an extract or a fraction of Pistacia weinmannifolia J. Poiss. Ex Franch for preventing or treating inflammatory-related diseases
KR101905009B1 (en) Polysaccharide fraction isolated from kale with immune-enhancing activity and method for producing the same
KR101503792B1 (en) Neuroprotective composition comprising extract or fractions of Vaccinium uliginosum as an active ingredient
JP2000086526A (en) Immunity activator and beverage containing the same
KR20210089345A (en) Manufacturing method of the Poria cocos Wolf extract
KR100515565B1 (en) Method of Extraction from Phellinus linteus Using Citric Acid Solution And Process of Polysaccharide Using The Same
KR101554071B1 (en) Pharmaceutical composition comprising maysin for the prevention and treatment of immunity reinforcement
RU2732625C1 (en) Method for production of marmalade for preventive purpose
KR101980624B1 (en) Composition for preventing, ameliorating or treating prostate cancer comprising fermented silkworm extract as effective component
KR20110081435A (en) Chrysanthemum indicum extract with improved anti-inflammatory activity by far infrared ray drying process and production method thereof
KR101068699B1 (en) Composition for antioxidation effect comprising sparassis crispa extract
KR101222779B1 (en) A composition comprising the extract of Barnyardgrass as an active ingredient for preventing and treating inflammatory disease
KR101989980B1 (en) Anticancer or immunactive polysaccharide from residues of immature citrus extract or immature citrus peel and composition comprising the same as an active ingredient
KR101964580B1 (en) Composition comprising an extract or a fraction of Codonopsis lanceolata for prevention and treatment of anti-inflammatory or asthma
KR102140702B1 (en) Galactouronoglucooligosaccharide Derived from Ginseng cake and Use Thereof
KR20050038852A (en) Composition comprising the extract of rubus coreanus having a effect of ataralgesia and antiphlogistic

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application